Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

ArQule and Daiichi Sankyo expand new kinase inhibitor discovery collaboration

Oct. 14, 2010

Genmab and Lundbeck to collaborate on human antibodies for CNS disorders

Oct. 14, 2010

Novartis to use ImmunoGen's TAP technology to develop anticancer therapeutics

Oct. 13, 2010

Exelixis and Bristol-Myers Squibb collaborate on multiple small-molecule programs

Oct. 13, 2010

Amylin Pharma to use Affibody's Albumod platform under new license agreement

Oct. 11, 2010

NephRx provides update on new peptides, NX-001 and NX-002

Oct. 11, 2010

Evotec and Shionogi form multiple-target drug discovery alliance

Oct. 6, 2010

Argenta and Janssen enter into cancer drug discovery agreement

Oct. 5, 2010

Domain Therapeutics describes new adenosine A2A and A3 receptor antagonists

Sep. 17, 2010

Pepscan Therapeutics and Tibotec form research collaboration

Sep. 16, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...